Z-2134-2021 Class II Terminated

Recalled by Cytocell Ltd. — Cambridge, N/A

FDA device recall Z-2134-2021 was initiated by Cytocell Ltd. on May 17, 2021 and is designated Class II. Reason for recall: The device may show unexpected locus specific signals in addition to those at 22q. Users may observe faint additional locus specific signals at 20p12/13. The recall status is terminated (terminated Aug 15, 2022). Affected quantity: 50.

Recall details

Product Type
Devices
Report Date
Aug 4, 2021
Initiation Date
May 17, 2021
Termination Date
Aug 15, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
50

Product description

CytoCell DiGeorge/VCFS TUPLE1 Region and 22q13.3 Region Probe, Model Number LPU004-A. analyte specific reagent for in vitro diagnostics

Reason for recall

The device may show unexpected locus specific signals in addition to those at 22q. Users may observe faint additional locus specific signals at 20p12/13.

Distribution pattern

Distribution to US states of CA, IL, MO, NY, PA, TX, and UT, and Canada.

Code information

Lot Numbers: 071399 072985

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2134-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2134-2021. Report a data issue: hello@regdatalab.com.